Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-21 Sale | 2025-08-21 5:44 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO | 7,616 | $400.18 | $3,047,756 | 109,753 (Direct) | View |
| 2025-08-18 Purchase | 2025-08-20 6:12 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 667 L.P. Baker Brothers Life Sciences LP Director | 97,065 | $380.58 | $36,941,197 | 1,947,968 (Indirect) | View |
| 2025-08-18 Purchase | 2025-08-20 6:09 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 667 L.P. Baker Brothers Life Sciences LP Director | 68,618 | $364.04 | $24,979,827 | 1,859,091 (Indirect) | View |
| 2025-08-18 Sale | 2025-08-18 5:33 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel | 1,304 | $367.81 | $479,627 | 9,173 (Direct) | View |
| 2025-08-15 Sale | 2025-08-15 6:04 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 10,000 | $365.2 | $3,652,009 | 2,627 (Direct) | View |
| 2025-08-13 Sale | 2025-08-13 6:18 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 129,172 | $370.24 | $47,825,149 | 842,704 (Indirect Direct) | View |
| 2025-08-11 Sale | 2025-08-13 5:45 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 46,808 | $355.31 | $16,631,386 | 1,144,653 (Indirect Direct) | View |
| 2025-08-11 Sale | 2025-08-13 5:33 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 46,463 | $355.32 | $16,509,032 | 1,159,847 (Indirect Direct) | View |
| 2025-07-18 Sale | 2025-07-22 5:08 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 1,000 | $350 | $350,005 | 1,163,047 (Indirect Direct) | View |
| 2025-07-18 Sale | 2025-07-22 5:06 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 1,400 | $350.03 | $490,044 | 1,018,684 (Indirect Direct) | View |
| 2025-07-16 Sale | 2025-07-18 4:13 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 28,876 | $353.19 | $10,198,844 | 1,200,164 (Indirect Direct) | View |
| 2025-07-16 Sale | 2025-07-18 4:11 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 29,101 | $353.19 | $10,278,098 | 1,214,167 (Indirect Direct) | View |
| 2025-03-12 Sale | 2025-03-14 4:25 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 15,470 | $328.54 | $5,082,480 | 391,289 (Indirect Direct) | View |
| 2025-03-10 Sale | 2025-03-12 4:32 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO | 258 | $323.04 | $83,344 | 10,440 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 5:40 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 14,113 | $341.32 | $4,817,104 | 14,383 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:36 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel | 415 | $335 | $139,025 | 7,290 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:31 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO | 1,961 | $324.96 | $637,248 | 6,914 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:24 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer | 1,834 | $325.98 | $597,840 | 8,604 (Direct) | View |
| 2025-02-28 Sale | 2025-03-04 9:24 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 1,227 | $341.07 | $418,488 | 3,728 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:31 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 15,470 | $347.45 | $5,375,126 | 1,912 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 20,000 | $356.44 | $7,128,759 | 7,382 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-15 Exercise | 2025-08-15 6:04 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 10,000 | $16.46 | 2,627 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-15 6:04 pm | N/A 2027-06-29 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 10,000 | $0 | 2,627 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-13 6:18 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 129,172 | $0 | 842,704 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-13 6:18 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 129,172 | $9.45 | 842,704 (Direct) | View |
| 2025-08-11 Exercise | 2025-08-13 5:45 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 46,808 | $0 | 1,144,653 (Direct) | View |
| 2025-08-11 Exercise | 2025-08-13 5:45 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 46,808 | $9.45 | 1,144,653 (Direct) | View |
| 2025-08-11 Exercise | 2025-08-13 5:33 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 46,463 | $0 | 1,159,847 (Direct) | View |
| 2025-08-11 Exercise | 2025-08-13 5:33 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 46,463 | $9.45 | 1,159,847 (Direct) | View |
| 2025-08-01 Option Award | 2025-08-05 7:23 pm | N/A 2035-08-01 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Brennan Daniel J. Director | 2,672 | $0 | 2,672 (Direct) | View |
| 2025-07-18 Exercise | 2025-07-22 5:08 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 1,000 | $0 | 1,163,047 (Direct) | View |
| 2025-07-18 Exercise | 2025-07-22 5:08 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 1,000 | $9.45 | 1,163,047 (Direct) | View |
| 2025-07-18 Exercise | 2025-07-22 5:06 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 1,400 | $0 | 1,018,684 (Direct) | View |
| 2025-07-18 Exercise | 2025-07-22 5:06 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 1,400 | $9.45 | 1,018,684 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 4:13 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 28,876 | $0 | 1,200,164 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 4:13 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 28,876 | $9.45 | 1,200,164 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 4:11 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 29,101 | $0 | 1,214,167 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 4:11 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 29,101 | $9.45 | 1,214,167 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:45 pm | N/A 2035-06-20 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 2,005 | $0 | 3,917 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:42 pm | N/A 2035-06-20 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 2,005 | $0 | 22,487 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:39 pm | N/A 2035-06-20 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FOUSE JACQUALYN A Director | 569 | $0 | 1,463 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:38 pm | N/A 2035-06-20 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 6,590 | $0 | 1,801,421 (Indirect) | View |
| 2025-06-20 Option Award | 2025-06-24 4:34 pm | N/A 2035-06-20 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 2,005 | $0 | 3,917 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:30 pm | N/A 2035-06-20 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 2,005 | $0 | 843,994 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 6:23 pm | N/A 2035-05-15 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Soergel David Chief Medical Officer | 20,384 | $0 | 20,384 (Direct) | View |
| 2025-04-10 Exercise | 2025-04-11 4:59 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 9,470 | $65.06 | 20,482 (Direct) | View |
| 2025-04-10 Exercise | 2025-04-11 4:59 pm | N/A 2025-06-16 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 9,470 | $0 | 20,482 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-14 4:25 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 9,470 | $65.06 | 391,289 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-14 4:25 pm | N/A 2025-06-16 | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 15,470 | $0 | 391,289 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-14 4:25 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 6,000 | $111.06 | 391,289 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-12 4:29 pm | N/A 2035-03-10 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FOUSE JACQUALYN A Director | 2,473 | $0 | 2,473 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 5:47 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO | 35,075 | $0 | 139,378 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 5:43 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO | 10,158 | $0 | 17,072 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 5:40 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 14,113 | $0 | 14,383 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 5:40 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,218 | $0 | 14,383 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 5:40 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 6,825 | $87.92 | 14,383 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 5:40 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 7,288 | $87.09 | 14,383 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 5:00 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 11,763 | $0 | 1,123,965 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:50 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel | 8,555 | $0 | 15,845 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:31 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer | 9,089 | $0 | 17,693 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:36 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO | 50,000 | $0 | 104,303 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:31 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 9,470 | $65.06 | 1,912 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:31 pm | N/A 2025-06-16 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 15,470 | $0 | 1,912 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:31 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 6,000 | $111.06 | 1,912 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 9,470 | $65.06 | 7,382 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:30 pm | N/A 2025-06-17 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 20,000 | $0 | 7,382 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 6,000 | $111.06 | 7,382 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 4,530 | $9.45 | 7,382 (Direct) | View |